Genomic sequencing data guides treatment of metastatic triple-negative breast cancer patients
Unprecedented genomic sequencing of 14 metastatic TNBC patients yields potential drug targets
Unprecedented genomic sequencing of 14 metastatic TNBC patients yields potential drug targets
Researchers at Case Western Reserve University School of Medicine have identified a molecule linked to more aggressive forms of breast cancer – a discovery that could point the… read more.
There is no difference between proton radiotherapy (PRT) and intensity-modulated radiotherapy (IMRT) when comparing the toxicity among patients with prostate cancer at 12 months post-treatment according to a… read more.
Research presented at the American Society for Cell Biology (ASCB) annual meeting, 15-19 December 2012, San Francisco.
by Gary Finnegan – EMA Highlights – The EMA has given its backing to a number of medicines including:
by Gary Finnegan – EMA Highlights – The first radiopharmaceutical for positron emission tomography (PET) imaging of β-amyloid neuritic plaque density has been approved by the EMA’s Committee… read more.
by Gary Finnegan – EMA Highlights – The EMA has given the green light to a new vaccine for bacterial meningitis. Bexsero, by Novartis, provides broad coverage against… read more.
by Gary Finnegan – EMA Highlights – The European Medicines Agency has pledged to boost transparency when deciding whether to allow companies to market their medicines for additional… read more.
by Bruce Sylvester – FDA Highlights – Treatment with denosumab decreases the number of tumor giant cells in patients with giant-cell tumor of the bone, and increases new… read more.
by Bruce Sylvester – FDA Highlights – According to a study published online on September 7, 2012 in the American Journal of Respiratory and Critical Care Medicine, treatment… read more.
by Bruce Sylvester – FDA Highlights – A study published online on August 27, 2012 in The Lancet suggests that gabapentin, a pain and seizure drug, significantly reduces… read more.
by Bruce Sylvester – taken from The Lancet – Radiotherapy given immediately after prostate removal surgery has a long-term benefit of preventing progression of the disease, researchers reported… read more.
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.